Ronald B. Moss insider trades: Adamis Pharmaceuticals (ADMP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ronald reports to the SEC
Open-market buys and sales
11 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 18, 2022 | ADMP | ↓ Sell10b5-1 | 8,199 | $0.60 | $5K | Direct | Mar 22, 2022 (4d) |
| Dec 1, 2021 | ADMP | ↓ Sell | 35,553 | $0.79 | $28K | Direct | Dec 3, 2021 (2d) |
| Nov 18, 2020 | ADMP | ↓ Sell | 8,532 | $0.41 | $3K | Direct | Nov 20, 2020 (2d) |
| Aug 18, 2020 | ADMP | ↓ Sell | 8,749 | $0.87 | $8K | Direct | Aug 20, 2020 (2d) |
| May 18, 2020 | ADMP | ↓ Sell | 7,736 | $0.56 | $4K | Direct | May 20, 2020 (2d) |
| Mar 18, 2020 | ADMP | ↓ Sell | 10,337 | $0.34 | $3K | Direct | Mar 19, 2020 (1d) |
| Feb 24, 2020 | ADMP | ↓ Sell | 6,229 | $0.06 | $396 | Direct | Feb 26, 2020 (2d) |
| Nov 18, 2019 | ADMP | ↓ Sell | 8,448 | $0.85 | $7K | Direct | Nov 20, 2019 (2d) |
| Aug 19, 2019 | ADMP | ↓ Sell | 8,383 | $1.06 | $9K | Direct | Aug 21, 2019 (2d) |
| May 20, 2019 | ADMP | ↓ Sell | 8,741 | $1.77 | $15K | Direct | May 22, 2019 (2d) |
| Mar 20, 2019 | ADMP | ↓ Sell | 6,647 | $2.27 | $15K | Direct | Mar 22, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Ronald B. Moss's insider trades
Ronald B. Moss is Chief Medical Officer at Adamis Pharmaceuticals (ADMP). Since Mar 20, 2019, Ronald has reported no open-market purchases and 11 sales worth $99K on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (5% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (3 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADMP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.